Navigation Links
Elevated protein levels in cardiac muscles could predict mortality following angioplasty
Date:5/12/2011

New research shows that elevated levels of cardiac troponin T (cTnT) or I (cTnI) in patients who had angioplasty indicate a higher risk of all-cause mortality and long-term adverse events such as heart attack. Routine monitoring of these protein levels following nonemergent percutaneous coronary intervention (PCI) could improve long-term outcomes for these patients. Details of the analysis are available online in Catheterization and Cardiovascular Interventions, a peer-reviewed journal of The Society for Cardiovascular Angiography and Interventions (SCAI).

More than one million Americans undergo coronary angioplasty each year to improve blood flow in blocked or narrowed arteries leading to the heart, according to the National Heart, Lung and Blood Institute. In cases where elective PCI was performed medical evidence has found that up to 30% of these patients experience minor elevations in cardiac enzymes, particularly levels of creatine kinase muscle-brain (CK-MB), which are associated with an increase in in-hospital adverse cardiac events. Greater elevations of CK-MB are associated with greater long-term mortality.

Recent studies suggest that elevated levels of cardiac troponins T or I are more specific indicators of cardiac muscle damage than CK-MB. However, conflicting data have been published in medical literature regarding the association between cardiac troponin elevation post-PCI and adverse cardiac events. In the current meta-analysis, Dmitriy Feldman, MD, FSCAI, and colleagues from New York Presbyterian Hospital and Weill Cornell Medical College, assessed the prevalence and mortality risk associated with elevated levels of cTnT or cTnI following elective PCI.

The research team conducted electronic and manual searches of all published studies reporting on the prognostic impact of cTnT or cTnI elevation following elective angioplasty. Twenty-two studies, published between 1998 and 2009, were identified and included 22,353 patients. A meta-analysisthe largest to dateof study findings showed that post-PCI levels of cTnT or cTnI were elevated in 26% and 34% of patients, respectively. The follow-up period of participants in the studies analyzed ranged from 3 to 67 months.

"Our analysis demonstrates that post-procedural elevation of cTnT or cTnI provides long-term prognostic information regarding mortality or myocardial infarction," said Dr. Feldman. Results showed that long-term all-cause mortality in patients with elevated cardiac troponin levels after PCI was 5.8% compared to only 4.4% in patients who did not experience an elevation in the cardiac enzymes. Adverse events (death or heart attack) following elective angioplasty were significantly higher in patients with elevated cTnT or cTnI levels (9.2%) compared to those without cTn elevations (5.3%). "Routine monitoring of peri-procedural cTn levels and more intensive outpatient monitoring and treatment of patients with cTn elevations following elective PCI may help to improve long-term adverse outcomes in these patients," Feldman advised.


'/>"/>

Contact: Dawn Peters
healthnews@wiley.com
781-388-8408
Wiley-Blackwell
Source:Eurekalert

Related medicine news :

1. Vegans elevated heart risk requires omega-3s and B12
2. Elevated levels of sodium blunt response to stress, study shows
3. Vegans elevated heart risk requires omega-3s and B12
4. Study of sarcoid-like granulomatous pulmonary disease finds elevated rates in WTC responders
5. Up to 8 percent of Canadian children suffer from elevated blood pressure
6. Death of Loved One May Trigger Elevated Heart Rate
7. Common Eye Condition Linked to Elevated Eye Pressure
8. Fathers incarceration associated with elevated risks of marijuana and other illegal drug use
9. Compounds in non-stick cookware may be associated with elevated cholesterol in children and teens
10. Elevated heart rate over time linked to significant risk of death
11. Biologics-naive juvenile idiopathic arthritis patients have elevated risk of cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... Advanced Spine ... to help restore its patients’ health, is hosting a free seminar on stem cell ... be held at Advanced Spine & Sport, 4601 Telephone Road, Suite 110, Ventura, CA. ...
(Date:5/4/2016)... ... 04, 2016 , ... Mediware Information Systems, Inc . ... that helps blood and marrow transplant (BMT) programs meet compliance and accreditation standards ... continued to enhance core application features. These enhancements are designed to help BMT ...
(Date:5/4/2016)... , ... May 04, 2016 , ... ... Scientific Group is scheduled on July 25-27, 2016 at Las Vegas. It aims ... care professionals from educational institutes and research organizations across the globe; making the ...
(Date:5/3/2016)... ... , ... The National Association of Professional Women (NAPW) honors ... Circle. She is recognized with this prestigious distinction for leadership in business. NAPW is ... and over 200 operating Local Chapters. , “I’m pleased to welcome Barbara into this ...
(Date:5/3/2016)... ... , ... Sue Desmond-Hellmann, chief executive officer of the Bill & Melinda Gates ... possibility in her keynote address at Georgia State University’s spring commencement on ... rich experience as a scientist, physician and executive, Desmond-Hellmann leads the Gates Foundation’s efforts ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... -- Intec Pharma Ltd. (NASDAQ: ... announced the appointment of Pnina Strauss-Levy as ... Strauss-Levy has 15 years of experience in clinical research ... record, having supported the advancement of several products through ... the United States and ...
(Date:5/3/2016)... 3, 2016 Norgine ... sie einen entscheidenden Meilenstein durch diese Veröffentlichung ... zum Handeln, um Patientenresultate  bei Verdauungs- und ... Fortschritten im Verständnis der Hepatischen Enzephalopathie bei ... für Hepatische Enzephalopathie in der Öffentlichkeit zu ...
(Date:5/2/2016)... 2, 2016  Deerfield announced today it led ... Vision, Inc. Graybug Vision is an early stage ... transform care for ocular diseases including wet age-related ... was first developed at Johns Hopkins University and ... Graybug Vision is developing ophthalmology ...
Breaking Medicine Technology: